10.3233/JPD-191900 29 ChuangY
Nadolsky says that for some of his patients at the highest dose of tirzepatide, the drug is sometimes "dampening that dopamine reward system down so much that now, instead of just getting away from those addictive behaviors, they don't feel like doing anything." Some of those high-dose patients start seeking out sugar, not due to cravings, he says, but because their bodies are searching for some kind of stimulation to get the reward system going again
Locke M, Heywood M, Fawell S, Mackenzie IC
[119] combined metabolomics with transcriptomics and found that ferroptosis was associated with Tripterygium wilfordii -induced testicular injury
The semaglutide onset timeline explains the expected progression
Gallups 2026 tracking shows a similar trajectory: 11 percent of American adults reported currently using a GLP-1 medication for weight loss purposes, up sharply from 3 percent in 2024